| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |